SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-053259
Filing Date
2020-11-12
Accepted
2020-11-12 07:05:08
Documents
68
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tyme-10q_20200930.htm 10-Q 1425483
2 EX-10.2 tyme-ex102_11.htm EX-10.2 46111
3 EX-31.1 tyme-ex311_6.htm EX-31.1 12497
4 EX-31.2 tyme-ex312_7.htm EX-31.2 12509
5 EX-32.1 tyme-ex321_8.htm EX-32.1 8340
  Complete submission text file 0001564590-20-053259.txt   5926101

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT tyme-20200930.xml EX-101.INS 1205472
7 XBRL TAXONOMY EXTENSION SCHEMA tyme-20200930.xsd EX-101.SCH 60271
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tyme-20200930_cal.xml EX-101.CAL 33648
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tyme-20200930_def.xml EX-101.DEF 186415
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE tyme-20200930_lab.xml EX-101.LAB 388100
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tyme-20200930_pre.xml EX-101.PRE 310708
Mailing Address 1 PLUCKEMIN WAY - SUITE 103 BEDMINSTER NJ 07921
Business Address 1 PLUCKEMIN WAY - SUITE 103 BEDMINSTER NJ 07921 212-461-2315
TYME TECHNOLOGIES, INC. (Filer) CIK: 0001537917 (see all company filings)

IRS No.: 453864597 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-38169 | Film No.: 201303298
SIC: 2834 Pharmaceutical Preparations